[
  {
    "title": "翰宇药业(300199.SZ)：维格列汀片获批上市并视同通过一致性评价",
    "href": "http://stock.jrj.com.cn/2023/01/05180237261934.shtml",
    "datetime": "2023-01-05 18:02:46",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：翰宇药业以集中竞价累计减持1.99%的股份",
    "href": "http://stock.jrj.com.cn/2022/12/28153637243054.shtml",
    "datetime": "2022-12-28 15:36:40",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业12月27日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/27181037241112.shtml",
    "datetime": "2022-12-27 18:10:24",
    "code": "300199"
  },
  {
    "title": "新冠药概念股大幅走低，翰宇药业逼近跌停",
    "href": "http://stock.jrj.com.cn/2022/12/27094737239685.shtml",
    "datetime": "2022-12-27 09:47:49",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：醋酸特利加压素原料药获得上市申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/12/16174837218684.shtml",
    "datetime": "2022-12-16 17:48:53",
    "code": "300199"
  },
  {
    "title": "翰宇药业创新进行时 新冠预防药物HY3000鼻喷雾剂获Ⅱ期伦理批件",
    "href": "http://stock.jrj.com.cn/2022/12/02211537185988.shtml",
    "datetime": "2022-12-02 21:15:16",
    "code": "300199"
  },
  {
    "title": "翰宇药业：HY3000预防新冠药获得II期临床试验组长单位伦理批件",
    "href": "http://stock.jrj.com.cn/2022/12/02195137185603.shtml",
    "datetime": "2022-12-02 19:51:56",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：HY3000预防新冠多肽鼻喷药物获得II期临床试验组长单位伦理批件",
    "href": "http://stock.jrj.com.cn/2022/12/02194237185583.shtml",
    "datetime": "2022-12-02 19:42:53",
    "code": "300199"
  },
  {
    "title": "A股异动丨翰宇药业创逾八个月新高 HY3000预防新冠多肽鼻喷药物已完成一期临床试验入组",
    "href": "http://stock.jrj.com.cn/2022/11/30094737176896.shtml",
    "datetime": "2022-11-30 09:47:43",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：HY3000预防新冠多肽鼻喷药物已完成一期临床试验入组",
    "href": "http://stock.jrj.com.cn/2022/11/29203237175707.shtml",
    "datetime": "2022-11-29 20:32:55",
    "code": "300199"
  },
  {
    "title": "翰宇药业：HY3000预防新冠多肽鼻喷药物已完成一期临床试验入组",
    "href": "http://stock.jrj.com.cn/2022/11/29183337175202.shtml",
    "datetime": "2022-11-29 18:33:54",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：醋酸去氨加压素原料药获得欧盟CEP证书",
    "href": "http://stock.jrj.com.cn/2022/11/16190737144503.shtml",
    "datetime": "2022-11-16 19:07:03",
    "code": "300199"
  },
  {
    "title": "A股异动 | 翰宇药业本月累涨逾46% 醋酸加尼瑞克原料药DMF获得FDA批准",
    "href": "http://stock.jrj.com.cn/2022/11/11104637130319.shtml",
    "datetime": "2022-11-11 10:46:12",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：醋酸加尼瑞克原料药DMF获得FDA批准",
    "href": "http://stock.jrj.com.cn/2022/11/10190737128613.shtml",
    "datetime": "2022-11-10 19:07:33",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：子公司被评选为湖北省绿色制造企业",
    "href": "http://stock.jrj.com.cn/2022/11/08172837120925.shtml",
    "datetime": "2022-11-08 17:28:17",
    "code": "300199"
  },
  {
    "title": "健麾信息：股东翰宇药业持股降至4.9999%",
    "href": "http://stock.jrj.com.cn/2022/11/07160837117115.shtml",
    "datetime": "2022-11-07 16:08:43",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：翰宇药业持股比例由5.19%减至4.9999%",
    "href": "http://stock.jrj.com.cn/2022/11/07153737116972.shtml",
    "datetime": "2022-11-07 15:37:12",
    "code": "300199"
  },
  {
    "title": "A股异动 | 翰宇药业涨超7% 与中国医药达成全面战略合作",
    "href": "http://stock.jrj.com.cn/2022/11/04100337111876.shtml",
    "datetime": "2022-11-04 10:03:55",
    "code": "300199"
  },
  {
    "title": "翰宇药业2022年前三季度亏损1.47亿同比亏损增加 股权激励摊销增加",
    "href": "http://stock.jrj.com.cn/2022/10/29115037096569.shtml",
    "datetime": "2022-10-29 11:50:45",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：第三季度净亏损4855.87万元",
    "href": "http://stock.jrj.com.cn/2022/10/28220737095965.shtml",
    "datetime": "2022-10-28 22:07:31",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：醋酸阿托西班原料药上市申请获批",
    "href": "http://stock.jrj.com.cn/2022/10/27163637089838.shtml",
    "datetime": "2022-10-27 16:36:14",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：翰宇药业以集中竞价累计减持1%的股份",
    "href": "http://stock.jrj.com.cn/2022/10/27141837089242.shtml",
    "datetime": "2022-10-27 14:18:47",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：依替巴肽原料药获得上市申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/09/28172637027968.shtml",
    "datetime": "2022-09-28 17:26:59",
    "code": "300199"
  },
  {
    "title": "翰宇药业：新冠抗原检测试剂盒项目将于近期申报器审中心",
    "href": "http://stock.jrj.com.cn/2022/09/25195737019611.shtml",
    "datetime": "2022-09-25 19:57:22",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：子公司醋酸奥曲肽原料药获批上市",
    "href": "http://stock.jrj.com.cn/2022/09/01164836963285.shtml",
    "datetime": "2022-09-01 16:48:22",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)上半年净亏损9822.31万元，同比多亏269.06%",
    "href": "http://stock.jrj.com.cn/2022/08/26194436942320.shtml",
    "datetime": "2022-08-26 19:44:33",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：HY3000新冠鼻喷雾剂I期临床试验获批",
    "href": "http://stock.jrj.com.cn/2022/08/24190836931636.shtml",
    "datetime": "2022-08-24 19:08:12",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：子公司醋酸去氨加压素原料药获批上市",
    "href": "http://stock.jrj.com.cn/2022/08/19164636916476.shtml",
    "datetime": "2022-08-19 16:46:41",
    "code": "300199"
  },
  {
    "title": "翰宇药业：全资子公司醋酸去氨加压素原料药获得上市申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/08/19164536916392.shtml",
    "datetime": "2022-08-19 16:45:39",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：HY3000鼻喷雾剂临床试验注册申请获受理",
    "href": "http://stock.jrj.com.cn/2022/08/04183336871007.shtml",
    "datetime": "2022-08-04 18:33:26",
    "code": "300199"
  },
  {
    "title": "翰宇药业：HY3000鼻喷雾剂临床试验注册申请获得受理",
    "href": "http://stock.jrj.com.cn/2022/08/04183336870992.shtml",
    "datetime": "2022-08-04 18:33:07",
    "code": "300199"
  },
  {
    "title": "翰宇药业：HY3000新冠多肽鼻喷项目主要用于预防",
    "href": "http://stock.jrj.com.cn/2022/08/02173636863313.shtml",
    "datetime": "2022-08-02 17:36:41",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：利拉鲁肽注射液获得境内生产药品注册上市许可受理通知书",
    "href": "http://stock.jrj.com.cn/2022/07/27200036848063.shtml",
    "datetime": "2022-07-27 20:00:39",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：子公司翰宇大理取得工业大麻加工许可证",
    "href": "http://stock.jrj.com.cn/2022/07/21160336832033.shtml",
    "datetime": "2022-07-21 16:03:37",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：利拉鲁肽原料药上市登记申请获受理",
    "href": "http://stock.jrj.com.cn/2022/07/19174136825657.shtml",
    "datetime": "2022-07-19 17:41:15",
    "code": "300199"
  },
  {
    "title": "第七批国家药品集采产生拟中选结果，立方制药、一品红、翰宇药业等多家公司公告多款产品拟中标",
    "href": "http://stock.jrj.com.cn/2022/07/12201636804628.shtml",
    "datetime": "2022-07-12 20:16:24",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：依替巴肽注射液拟中选第七批国采",
    "href": "http://stock.jrj.com.cn/2022/07/12182636804217.shtml",
    "datetime": "2022-07-12 18:26:33",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：翰宇药业拟提前终止减持计划 已累计减持1.11%股份",
    "href": "http://stock.jrj.com.cn/2022/07/06203536788379.shtml",
    "datetime": "2022-07-06 20:35:25",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：拟出售不超408万股健麾信息股票",
    "href": "http://stock.jrj.com.cn/2022/07/06170036787424.shtml",
    "datetime": "2022-07-06 17:00:34",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：翰宇药业累计减持1.17%股份",
    "href": "http://stock.jrj.com.cn/2022/06/21154736746206.shtml",
    "datetime": "2022-06-21 15:47:24",
    "code": "300199"
  },
  {
    "title": "翰宇药业：多肽鼻喷剂项目细分赛道竞争厂家相对可控",
    "href": "http://stock.jrj.com.cn/2022/06/01190936697894.shtml",
    "datetime": "2022-06-01 19:09:13",
    "code": "300199"
  },
  {
    "title": "健麾信息：股东翰宇药业已减持约142.11万股 占公司总股本比例1.05%",
    "href": "http://stock.jrj.com.cn/2022/05/20164136665993.shtml",
    "datetime": "2022-05-20 16:41:52",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：翰宇药业已累计减持2.10%股份 持股降至8.09%",
    "href": "http://stock.jrj.com.cn/2022/05/20154936665666.shtml",
    "datetime": "2022-05-20 15:49:40",
    "code": "300199"
  },
  {
    "title": "翰宇药业收2021年报问询函：毛利率在国内74%在国外47% 被要求说明原因",
    "href": "http://stock.jrj.com.cn/2022/05/17101036654107.shtml",
    "datetime": "2022-05-17 10:10:52",
    "code": "300199"
  },
  {
    "title": "翰宇药业：新冠多肽鼻喷剂项目获受理",
    "href": "http://stock.jrj.com.cn/2022/05/12211036644308.shtml",
    "datetime": "2022-05-12 21:10:45",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：将以原价回购大众交通持有的翰宇大理10.81%股权",
    "href": "http://stock.jrj.com.cn/2022/05/09213236610980.shtml",
    "datetime": "2022-05-09 21:32:10",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：向204名激励对象授予1440万股限制性股票",
    "href": "http://stock.jrj.com.cn/2022/05/09212936610943.shtml",
    "datetime": "2022-05-09 21:29:11",
    "code": "300199"
  },
  {
    "title": "翰宇药业2022年第一季度亏损5765.48万同比由盈转亏 投资收益同比减少",
    "href": "http://stock.jrj.com.cn/2022/05/04195036558918.shtml",
    "datetime": "2022-05-04 19:50:44",
    "code": "300199"
  },
  {
    "title": "翰宇药业2021年净利3080.78万同比扭亏为盈 董事长曾少贵薪酬100.57万",
    "href": "http://stock.jrj.com.cn/2022/04/28231036496538.shtml",
    "datetime": "2022-04-28 23:10:31",
    "code": "300199"
  },
  {
    "title": "翰宇药业：新冠鼻喷项目获国家药审中心针对性回复",
    "href": "http://stock.jrj.com.cn/2022/04/19200336401938.shtml",
    "datetime": "2022-04-19 20:03:47",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：家用型新型冠状病毒抗原检测试剂盒近期通过了中国食品药品鉴定研究院检测",
    "href": "http://stock.jrj.com.cn/2022/04/18221436387857.shtml",
    "datetime": "2022-04-18 22:14:59",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：合作成立合成生物学与多肽药物联合研究中心",
    "href": "http://stock.jrj.com.cn/2022/04/15182636346013.shtml",
    "datetime": "2022-04-15 18:26:51",
    "code": "300199"
  },
  {
    "title": "翰宇药业大手笔激励20%员工：授予价格仅为股价50% 研发进度被列入考核指标",
    "href": "http://stock.jrj.com.cn/2022/03/25113035067294.shtml",
    "datetime": "2022-03-25 11:30:44",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)拟推1800万股的2022年限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2022/03/24211434941975.shtml",
    "datetime": "2022-03-24 21:14:37",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：注射用特利加压素获得巴西上市许可批准",
    "href": "http://stock.jrj.com.cn/2022/03/23204134873668.shtml",
    "datetime": "2022-03-23 20:41:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：奥曲肽原料药获得欧盟CEP证书",
    "href": "http://stock.jrj.com.cn/2022/03/15180634830105.shtml",
    "datetime": "2022-03-15 18:06:41",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：拟与国研中心、市三院合作开发家用快速型新型冠状病毒抗原检测试剂盒",
    "href": "http://stock.jrj.com.cn/2022/03/14224634826225.shtml",
    "datetime": "2022-03-14 22:46:12",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业3月8日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/08180434541937.shtml",
    "datetime": "2022-03-08 18:04:00",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业2月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/24180534452818.shtml",
    "datetime": "2022-02-24 18:05:22",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业2月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/23180434447672.shtml",
    "datetime": "2022-02-23 18:04:11",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：控股股东及其行动人解除质押4400万股",
    "href": "http://stock.jrj.com.cn/2022/02/18171534392500.shtml",
    "datetime": "2022-02-18 17:15:12",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业2月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/02/17180534382560.shtml",
    "datetime": "2022-02-17 18:05:14",
    "code": "300199"
  },
  {
    "title": "A股异动丨翰宇药业涨超7% 新冠多肽鼻喷剂项目已完成对奥密克戎及德尔塔流行株的活病毒研究",
    "href": "http://stock.jrj.com.cn/2022/02/17094034378682.shtml",
    "datetime": "2022-02-17 09:40:17",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：曾少彬解除质押300万股",
    "href": "http://stock.jrj.com.cn/2022/02/07194434302886.shtml",
    "datetime": "2022-02-07 19:44:21",
    "code": "300199"
  },
  {
    "title": "翰宇药业受累集采主业连亏4年 内控严重缺位两核心高管被刑拘",
    "href": "http://stock.jrj.com.cn/2022/01/26170134223983.shtml",
    "datetime": "2022-01-26 17:01:40",
    "code": "300199"
  },
  {
    "title": "早盘大跌9%！涉嫌贪腐，这家公司原总裁被批捕",
    "href": "http://stock.jrj.com.cn/2022/01/26121534222513.shtml",
    "datetime": "2022-01-26 12:15:20",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业1月25日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/25180534213113.shtml",
    "datetime": "2022-01-25 18:05:02",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司原董事、高级管理人员被采取刑事强制措施",
    "href": "http://stock.jrj.com.cn/2022/01/25170134212456.shtml",
    "datetime": "2022-01-25 17:01:10",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：翰宇药业累计减持1.05%股份",
    "href": "http://stock.jrj.com.cn/2022/01/25160434210081.shtml",
    "datetime": "2022-01-25 16:04:10",
    "code": "300199"
  },
  {
    "title": "翰宇药业2021年预计净利2500万-3750万同比扭亏为盈 投资收益增长",
    "href": "http://stock.jrj.com.cn/2022/01/24203034206265.shtml",
    "datetime": "2022-01-24 20:30:09",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)2021年度预盈2500万-3750万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2022/01/24174334205191.shtml",
    "datetime": "2022-01-24 17:43:48",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：曾少彬质押300万股",
    "href": "http://stock.jrj.com.cn/2022/01/21223134184529.shtml",
    "datetime": "2022-01-21 22:31:29",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人曾少贵解押及质押2390万股",
    "href": "http://stock.jrj.com.cn/2022/01/17210834166279.shtml",
    "datetime": "2022-01-17 21:08:12",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：与中国科学院微生物研究所合作开发新型冠状病毒多肽鼻喷剂药物",
    "href": "http://stock.jrj.com.cn/2022/01/17210434166262.shtml",
    "datetime": "2022-01-17 21:04:16",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：再次取得高新技术企业认证",
    "href": "http://stock.jrj.com.cn/2022/01/17200334165985.shtml",
    "datetime": "2022-01-17 20:03:09",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业1月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/17180634165482.shtml",
    "datetime": "2022-01-17 18:06:03",
    "code": "300199"
  },
  {
    "title": "新冠特效药概念股集体走强，舒泰神、翰宇药业20CM涨停",
    "href": "http://stock.jrj.com.cn/2022/01/17133234163592.shtml",
    "datetime": "2022-01-17 13:32:11",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业1月14日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/14180534158492.shtml",
    "datetime": "2022-01-14 18:05:23",
    "code": "300199"
  },
  {
    "title": "A股异动 | 翰宇药业涨15% 醋酸阿托西班注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/14110534157003.shtml",
    "datetime": "2022-01-14 11:05:23",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：醋酸阿托西班注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/01/13170034154470.shtml",
    "datetime": "2022-01-13 17:00:17",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：控股股东曾少强解除质押及质押回购2000万股",
    "href": "http://stock.jrj.com.cn/2022/01/11170434146481.shtml",
    "datetime": "2022-01-11 17:04:51",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司有四款妇产及辅助生殖领域用药",
    "href": "http://stock.jrj.com.cn/2022/01/11144334145829.shtml",
    "datetime": "2022-01-11 14:43:20",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业1月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/04180634121802.shtml",
    "datetime": "2022-01-04 18:06:31",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：深投控12月31日大宗交易减持1.0743%股份",
    "href": "http://stock.jrj.com.cn/2021/12/31185334094127.shtml",
    "datetime": "2021-12-31 18:53:20",
    "code": "300199"
  },
  {
    "title": "A股异动 | 翰宇药业涨停 已完成针对密克戎变异株假病毒的中和实验",
    "href": "http://stock.jrj.com.cn/2021/12/31130934092470.shtml",
    "datetime": "2021-12-31 13:09:55",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业12月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/12/30180534087547.shtml",
    "datetime": "2021-12-30 18:05:01",
    "code": "300199"
  },
  {
    "title": "A股异动 | 翰宇药业涨停 与大理大学附属医院、药学院共建医疗机构制剂产业化平台",
    "href": "http://stock.jrj.com.cn/2021/12/30133034086357.shtml",
    "datetime": "2021-12-30 13:30:51",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：注射用特利加压素通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/12/28174234076924.shtml",
    "datetime": "2021-12-28 17:42:29",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：变更对参股公司健麾信息的会计核算方法",
    "href": "http://stock.jrj.com.cn/2021/12/24171334058288.shtml",
    "datetime": "2021-12-24 17:13:14",
    "code": "300199"
  },
  {
    "title": "A股异动 | 翰宇药业(300199.SZ)涨5% 拟择机出售健麾信息不超816万股",
    "href": "http://stock.jrj.com.cn/2021/12/24142434057292.shtml",
    "datetime": "2021-12-24 14:24:12",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：拟增加翰宇创新产业大楼项目投资预算至8.55亿元",
    "href": "http://stock.jrj.com.cn/2021/12/23211434054352.shtml",
    "datetime": "2021-12-23 21:14:35",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：拟择机出售健麾信息不超816万股",
    "href": "http://stock.jrj.com.cn/2021/12/23203834054198.shtml",
    "datetime": "2021-12-23 20:38:51",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：翰宇药业拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2021/12/23160534052835.shtml",
    "datetime": "2021-12-23 16:05:18",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人曾少贵解押及质押均为2200万股",
    "href": "http://stock.jrj.com.cn/2021/12/10173633995148.shtml",
    "datetime": "2021-12-10 17:36:34",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：控股股东曾少强解质及质押回购2200万股",
    "href": "http://stock.jrj.com.cn/2021/12/06170233974122.shtml",
    "datetime": "2021-12-06 17:02:20",
    "code": "300199"
  },
  {
    "title": "翰宇药业选举曾少贵为董事长 第三季度公司亏损9145.75万",
    "href": "http://stock.jrj.com.cn/2021/12/01221133951922.shtml",
    "datetime": "2021-12-01 22:11:11",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：缩宫素原料药获得欧盟CEP证书",
    "href": "http://stock.jrj.com.cn/2021/11/19194333881606.shtml",
    "datetime": "2021-11-19 19:43:36",
    "code": "300199"
  },
  {
    "title": "翰宇药业回复关注函：多肽新药存在上市后市场竞争格局的不确定性",
    "href": "http://stock.jrj.com.cn/2021/11/17213533868054.shtml",
    "datetime": "2021-11-17 21:35:35",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业11月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/17180333867075.shtml",
    "datetime": "2021-11-17 18:03:30",
    "code": "300199"
  },
  {
    "title": "翰宇药业：一份授权专利，23.86亿的市值礼包",
    "href": "http://stock.jrj.com.cn/2021/11/17083033864220.shtml",
    "datetime": "2021-11-17 08:30:10",
    "code": "300199"
  },
  {
    "title": "6天涨95%！消息未公告股价先动！深圳这家企业再“蹭热度”，800万预付款买新冠鼻喷剂 爆料人：要步康美后尘",
    "href": "http://stock.jrj.com.cn/2021/11/16134333859734.shtml",
    "datetime": "2021-11-16 13:43:10",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)续涨再创阶段新高 6个交易日累涨超120%",
    "href": "http://stock.jrj.com.cn/2021/11/16094133858670.shtml",
    "datetime": "2021-11-16 09:41:53",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人及一致行动人解押1020万股、质押640万股",
    "href": "http://stock.jrj.com.cn/2021/11/15170133854920.shtml",
    "datetime": "2021-11-15 17:01:19",
    "code": "300199"
  },
  {
    "title": "A股异动 | 翰宇药业一字涨停 与中国科学院微生物研究所合作开发新型冠状病毒多肽鼻喷剂药物",
    "href": "http://stock.jrj.com.cn/2021/11/15101033853142.shtml",
    "datetime": "2021-11-15 10:10:25",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业11月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/12180433841862.shtml",
    "datetime": "2021-11-12 18:04:13",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：曾少贵解押及质押1919万股、曾少强质押80万股及曾少彬质押300万股",
    "href": "http://stock.jrj.com.cn/2021/11/06170433819534.shtml",
    "datetime": "2021-11-06 17:04:40",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：注射用生长抑素通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/11/05183633817683.shtml",
    "datetime": "2021-11-05 18:36:55",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：醋酸特利加压素原料药获得欧盟CEP证书",
    "href": "http://stock.jrj.com.cn/2021/11/01203733799726.shtml",
    "datetime": "2021-11-01 20:37:21",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：盐酸普拉克索缓释片获批上市并视同通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/10/12213033681147.shtml",
    "datetime": "2021-10-12 21:30:35",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人及其一致行动人合计解押3400万股及质押4400万股",
    "href": "http://stock.jrj.com.cn/2021/09/06173233392850.shtml",
    "datetime": "2021-09-06 17:32:17",
    "code": "300199"
  },
  {
    "title": "连续三年巨亏，财务数据有猫腻，这家深圳药企终被监管盯上",
    "href": "http://stock.jrj.com.cn/2021/09/04175133384512.shtml",
    "datetime": "2021-09-04 17:51:15",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：深交所给予公司及相关当事人通报批评处分",
    "href": "http://stock.jrj.com.cn/2021/09/03163633380353.shtml",
    "datetime": "2021-09-03 16:36:39",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)上半年净亏损2661.42万元 同比转亏",
    "href": "http://stock.jrj.com.cn/2021/08/27234533337081.shtml",
    "datetime": "2021-08-27 23:45:33",
    "code": "300199"
  },
  {
    "title": "翰宇药业2021年半年度亏损2661.42万元 同比由盈转亏",
    "href": "http://stock.jrj.com.cn/2021/08/27225633336866.shtml",
    "datetime": "2021-08-27 22:56:41",
    "code": "300199"
  },
  {
    "title": "翰宇药业对2020年业绩预测出现严重偏差：董事长曾少贵等四高管被警示",
    "href": "http://stock.jrj.com.cn/2021/08/18183133275030.shtml",
    "datetime": "2021-08-18 18:31:23",
    "code": "300199"
  },
  {
    "title": "翰宇药业副总裁朱文丰辞职 2020年薪酬为88.92万",
    "href": "http://stock.jrj.com.cn/2021/08/09205933227265.shtml",
    "datetime": "2021-08-09 20:59:17",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人方面协议转让给赖建生、彭彤的9169.2704万股已完成过户",
    "href": "http://stock.jrj.com.cn/2021/07/26222833154204.shtml",
    "datetime": "2021-07-26 22:28:23",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人之一致行动人解押约1834.64万股",
    "href": "http://stock.jrj.com.cn/2021/07/26205933153891.shtml",
    "datetime": "2021-07-26 20:59:02",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人曾少贵向赖汉宣转让5%股份事项终止",
    "href": "http://stock.jrj.com.cn/2021/07/12212433084482.shtml",
    "datetime": "2021-07-12 21:24:27",
    "code": "300199"
  },
  {
    "title": "翰宇药业：控股股东、实控人及其一致行动人所持合计2773万股解除质押",
    "href": "http://stock.jrj.com.cn/2021/07/12202433084371.shtml",
    "datetime": "2021-07-12 20:24:08",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：财务总监魏红辞职 由涂鸿鸿接任",
    "href": "http://stock.jrj.com.cn/2021/07/12193533083995.shtml",
    "datetime": "2021-07-12 19:35:21",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人方面拟向赖汉宣、彭彤分别转让5.19%的股份",
    "href": "http://stock.jrj.com.cn/2021/07/02201633035089.shtml",
    "datetime": "2021-07-02 20:16:58",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人曾少贵解除质押800万股",
    "href": "http://stock.jrj.com.cn/2021/06/25173832997197.shtml",
    "datetime": "2021-06-25 17:38:53",
    "code": "300199"
  },
  {
    "title": "翰宇药业控股股东曾少强质押800万股 用于融资",
    "href": "http://stock.jrj.com.cn/2021/06/23195332984699.shtml",
    "datetime": "2021-06-23 19:53:07",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人曾少强质押800万股",
    "href": "http://stock.jrj.com.cn/2021/06/23173432983762.shtml",
    "datetime": "2021-06-23 17:34:04",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：拟向控股子公司翰宇大理增资1500万元",
    "href": "http://stock.jrj.com.cn/2021/06/21205232971551.shtml",
    "datetime": "2021-06-21 20:52:54",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：拟非公开发行不超5亿元公司债",
    "href": "http://stock.jrj.com.cn/2021/06/21204832971530.shtml",
    "datetime": "2021-06-21 20:48:14",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：注射用胸腺法新通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/06/16193232941976.shtml",
    "datetime": "2021-06-16 19:32:51",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司的多肽护肤品现已在网络渠道形成销售",
    "href": "http://stock.jrj.com.cn/2021/06/11192632912917.shtml",
    "datetime": "2021-06-11 19:26:09",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：股东翰宇药业解押约1385.36万股",
    "href": "http://stock.jrj.com.cn/2021/06/11164032911856.shtml",
    "datetime": "2021-06-11 16:40:55",
    "code": "300199"
  },
  {
    "title": "健麾信息股东翰宇药业质押1385.36万股 用于非融资类质押",
    "href": "http://stock.jrj.com.cn/2021/06/07192932888353.shtml",
    "datetime": "2021-06-07 19:29:16",
    "code": "300199"
  },
  {
    "title": "健麾信息(605186.SH)：股东翰宇药业质押约1385万股",
    "href": "http://stock.jrj.com.cn/2021/06/07184432887842.shtml",
    "datetime": "2021-06-07 18:44:36",
    "code": "300199"
  },
  {
    "title": "翰宇药业紧急驰援广州地区防疫物资",
    "href": "http://stock.jrj.com.cn/2021/06/04091432872627.shtml",
    "datetime": "2021-06-04 09:14:15",
    "code": "300199"
  },
  {
    "title": "健麾信息自揭风险难挡股价七连板 翰宇药业8400万入股五年已赚4.25亿",
    "href": "http://stock.jrj.com.cn/2021/06/03072232876344.shtml",
    "datetime": "2021-06-03 07:22:39",
    "code": "300199"
  },
  {
    "title": "翰宇药业2020年亏损6.09亿 董事长曾少贵薪酬99.33万",
    "href": "http://stock.jrj.com.cn/2021/04/30104032485405.shtml",
    "datetime": "2021-04-30 10:40:44",
    "code": "300199"
  },
  {
    "title": "翰宇药业：2020年度从公司实际出发 不进行利润分配 也不进行资本公积金转增股本",
    "href": "http://stock.jrj.com.cn/2021/04/29202232482106.shtml",
    "datetime": "2021-04-29 20:22:46",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司的护肤品已在网络渠道形成销售",
    "href": "http://stock.jrj.com.cn/2021/04/29202232482107.shtml",
    "datetime": "2021-04-29 20:22:21",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司子公司翰宇生物科技（大理）有限公司工业大麻深加工基地项目进展顺利",
    "href": "http://stock.jrj.com.cn/2021/04/29193132481788.shtml",
    "datetime": "2021-04-29 19:31:23",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司已有卡贝缩宫素注射液、曲美他嗪缓释片、二甲双胍缓释片三个品种通过或视同通过一致性评价",
    "href": "http://stock.jrj.com.cn/2021/04/29192832481761.shtml",
    "datetime": "2021-04-29 19:28:17",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)一季度净利升4.66%至2346.60万元",
    "href": "http://stock.jrj.com.cn/2021/04/29105932478729.shtml",
    "datetime": "2021-04-29 10:59:42",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)2020年净亏损6.09亿元 同比减亏31.12%",
    "href": "http://stock.jrj.com.cn/2021/04/29105432478708.shtml",
    "datetime": "2021-04-29 10:54:29",
    "code": "300199"
  },
  {
    "title": "去年业绩由“预盈变预亏” 翰宇药业“变脸”后将连亏三年",
    "href": "http://stock.jrj.com.cn/2021/04/14071632368792.shtml",
    "datetime": "2021-04-14 07:16:18",
    "code": "300199"
  },
  {
    "title": "去年业绩由“预盈变预亏” 翰宇药业“变脸”后将连亏三年",
    "href": "http://stock.jrj.com.cn/2021/04/13203532366954.shtml",
    "datetime": "2021-04-13 20:35:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业突然修正业绩引交易所“关注” 销售费用奇高致净利润连年缩水",
    "href": "http://stock.jrj.com.cn/2021/04/13082332362989.shtml",
    "datetime": "2021-04-13 08:23:00",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业4月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/04/12180532358632.shtml",
    "datetime": "2021-04-12 18:05:03",
    "code": "300199"
  },
  {
    "title": "A股异动 | 翰宇药业(300199.SZ)大跌超17%创近8年新低 去年预亏5.5亿-6.5亿元",
    "href": "http://stock.jrj.com.cn/2021/04/12093432355804.shtml",
    "datetime": "2021-04-12 09:34:22",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)修正业绩预告：2020年度预亏5.5亿-6.5亿元",
    "href": "http://stock.jrj.com.cn/2021/04/09201632344277.shtml",
    "datetime": "2021-04-09 20:16:14",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：解除相关基金合作协议",
    "href": "http://stock.jrj.com.cn/2021/04/02192432271854.shtml",
    "datetime": "2021-04-02 19:24:04",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：控股股东、实控人之曾少贵、曾少彬合计解除质押3378万股",
    "href": "http://stock.jrj.com.cn/2021/03/22163332194666.shtml",
    "datetime": "2021-03-22 16:33:52",
    "code": "300199"
  },
  {
    "title": "翰宇药业：利拉鲁肽注射液目前正在按国家局审评认证中心要求进行临床实验",
    "href": "http://stock.jrj.com.cn/2021/03/18175632158267.shtml",
    "datetime": "2021-03-18 17:56:16",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：控股股东、实控人之曾少强、曾少彬合计解押1280万股",
    "href": "http://stock.jrj.com.cn/2021/03/12172232116351.shtml",
    "datetime": "2021-03-12 17:22:13",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：三位实控人合计解除质押2583.15万股",
    "href": "http://stock.jrj.com.cn/2021/03/11174332110140.shtml",
    "datetime": "2021-03-11 17:43:16",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：卡贝缩宫素注射液通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2021/03/11174232110135.shtml",
    "datetime": "2021-03-11 17:42:26",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人之一曾少彬解押1100万股",
    "href": "http://stock.jrj.com.cn/2021/03/03163732063968.shtml",
    "datetime": "2021-03-03 16:37:07",
    "code": "300199"
  },
  {
    "title": "翰宇药业2020年预计净利2000万–3000万同比扭亏为盈 对健麾信息投资定位的调整",
    "href": "http://stock.jrj.com.cn/2021/01/30201931815543.shtml",
    "datetime": "2021-01-30 20:19:10",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司注射用特利加压素在国内市场的占有率在75-80%左右",
    "href": "http://stock.jrj.com.cn/2021/01/22185931746696.shtml",
    "datetime": "2021-01-22 18:59:42",
    "code": "300199"
  },
  {
    "title": "翰宇药业：目前口罩产品在国内国外、线上线下均有销售",
    "href": "http://stock.jrj.com.cn/2021/01/22170131745581.shtml",
    "datetime": "2021-01-22 17:01:55",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人曾少贵解押及质押均为2413万股",
    "href": "http://stock.jrj.com.cn/2021/01/19174831722822.shtml",
    "datetime": "2021-01-19 17:48:34",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：超募资金投资项目结项 剩余募集资金永久补充流动资金",
    "href": "http://stock.jrj.com.cn/2021/01/14192731693366.shtml",
    "datetime": "2021-01-14 19:27:57",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：曾少强解除质押及质押2000万股",
    "href": "http://stock.jrj.com.cn/2021/01/14192131693350.shtml",
    "datetime": "2021-01-14 19:21:25",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：子公司翰宇大理拟增资扩股引进大众交通 公司放弃优先认购权",
    "href": "http://stock.jrj.com.cn/2021/01/14191931693343.shtml",
    "datetime": "2021-01-14 19:19:21",
    "code": "300199"
  },
  {
    "title": "信息披露不及时、财务核算不准确 翰宇药业被采取行政监管措施",
    "href": "http://stock.jrj.com.cn/2021/01/07165131648573.shtml",
    "datetime": "2021-01-07 16:51:47",
    "code": "300199"
  },
  {
    "title": "问题多多 被责令改正 翰宇药业已连亏两年 能否够摆脱“ST”？",
    "href": "http://stock.jrj.com.cn/2021/01/07084131686831.shtml",
    "datetime": "2021-01-07 08:41:00",
    "code": "300199"
  },
  {
    "title": "问题多多 被责令改正 翰宇药业已连亏两年 能否够摆脱“ST”？",
    "href": "http://stock.jrj.com.cn/2021/01/07084131690494.shtml",
    "datetime": "2021-01-07 08:41:00",
    "code": "300199"
  },
  {
    "title": "问题多多 被责令改正 翰宇药业已连亏两年 能否够摆脱“ST”？",
    "href": "http://stock.jrj.com.cn/2021/01/07084131646098.shtml",
    "datetime": "2021-01-07 08:41:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：控股股东及其一致行动人合计解押及质押3378万股",
    "href": "http://stock.jrj.com.cn/2021/01/04162631627379.shtml",
    "datetime": "2021-01-04 16:26:56",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]热烈庆祝翰宇药业投资企业健麾信息成功登陆上交所主板!",
    "href": "http://stock.jrj.com.cn/2020/12/22000031546637.shtml",
    "datetime": "2020-12-22 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业精彩亮相CPhI & P-MEC China会展",
    "href": "http://stock.jrj.com.cn/2020/12/22000031544844.shtml",
    "datetime": "2020-12-22 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]清华大学深圳国际研究生院邢教授、马岚教授一行来访翰宇药业",
    "href": "http://stock.jrj.com.cn/2020/12/22000031824232.shtml",
    "datetime": "2020-12-22 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]武汉市长周先旺一行赴翰宇武汉公司实地考察",
    "href": "http://stock.jrj.com.cn/2020/12/22000031824230.shtml",
    "datetime": "2020-12-22 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：实控人曾少贵解押及质押2330万股",
    "href": "http://stock.jrj.com.cn/2020/12/21163831536784.shtml",
    "datetime": "2020-12-21 16:38:30",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]深圳市市委常委杨洪莅临我司调研",
    "href": "http://stock.jrj.com.cn/2020/12/18000031824228.shtml",
    "datetime": "2020-12-18 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：拟增加成纪药业为翰宇武汉部分贷款提供担保",
    "href": "http://stock.jrj.com.cn/2020/12/10170131456804.shtml",
    "datetime": "2020-12-10 17:01:31",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：拟以翰宇创新产业大楼项目的土地及房产提供抵押 向银行申请综合授信9.5亿元",
    "href": "http://stock.jrj.com.cn/2020/12/10164931456683.shtml",
    "datetime": "2020-12-10 16:49:47",
    "code": "300199"
  },
  {
    "title": "翰宇药业：重磅产品专利到期有利拉鲁肽、格拉替雷、杜拉鲁肽等",
    "href": "http://stock.jrj.com.cn/2020/12/09135231448322.shtml",
    "datetime": "2020-12-09 13:52:26",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：曾少贵及曾少强合计解除质押及质押2200万股",
    "href": "http://stock.jrj.com.cn/2020/12/08171831441092.shtml",
    "datetime": "2020-12-08 17:18:09",
    "code": "300199"
  },
  {
    "title": "翰宇药业：目前全球多肽行业市场容量逐年上升国内多肽药物市场份额逐年上升",
    "href": "http://stock.jrj.com.cn/2020/12/08170431440971.shtml",
    "datetime": "2020-12-08 17:04:41",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司是国内多肽细分领域的龙头企业",
    "href": "http://stock.jrj.com.cn/2020/12/08165831440907.shtml",
    "datetime": "2020-12-08 16:58:18",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司在甘肃成纪药业设立了口罩生产线 面向国内外销售",
    "href": "http://stock.jrj.com.cn/2020/12/08155331440113.shtml",
    "datetime": "2020-12-08 15:53:23",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司紧密围绕多肽应用场景进行仿制药、创新药的战略级布局 且在美容肽等新兴产业进行试点",
    "href": "http://stock.jrj.com.cn/2020/12/07181631431993.shtml",
    "datetime": "2020-12-07 18:16:28",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]云南省科技厅厅长董保同一行莅临翰宇药业调研",
    "href": "http://stock.jrj.com.cn/2020/11/16000031292456.shtml",
    "datetime": "2020-11-16 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]武汉市委副书记、市长周先旺:全力支持翰宇药业深耕武汉",
    "href": "http://stock.jrj.com.cn/2020/11/16000031336427.shtml",
    "datetime": "2020-11-16 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司子公司翰宇生物科技（大理）有限公司工业大麻深加工基地项目进展顺利",
    "href": "http://stock.jrj.com.cn/2020/11/13222231278016.shtml",
    "datetime": "2020-11-13 22:22:14",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司投资健麾信息有助于丰富在智慧医疗的布局 完善公司产业链条",
    "href": "http://stock.jrj.com.cn/2020/11/13184331276835.shtml",
    "datetime": "2020-11-13 18:43:26",
    "code": "300199"
  },
  {
    "title": "翰宇药业2020年前三季度净利5590.42万增长169.84% 资产减值损失下滑",
    "href": "http://stock.jrj.com.cn/2020/10/28142431150621.shtml",
    "datetime": "2020-10-28 14:24:44",
    "code": "300199"
  },
  {
    "title": "翰宇药业：2020年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/28012031145785.shtml",
    "datetime": "2020-10-28 01:20:14",
    "code": "300199"
  },
  {
    "title": "翰宇药业(300199.SZ)：参股公司健麾信息首发申请获得通过",
    "href": "http://stock.jrj.com.cn/2020/10/25181031123378.shtml",
    "datetime": "2020-10-25 18:10:24",
    "code": "300199"
  },
  {
    "title": "甘肃通报药企处置整改情况 涉翰宇药业农发行旗下公司",
    "href": "http://stock.jrj.com.cn/2020/10/12190931033367.shtml",
    "datetime": "2020-10-12 19:09:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业收监管函 披露回购不低于4亿元实际回购3.2亿",
    "href": "http://stock.jrj.com.cn/2020/09/29164730860388.shtml",
    "datetime": "2020-09-29 16:47:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：公司的盐酸曲美他嗪缓释片在2020年1月的国家集采项目中以第一顺位中选",
    "href": "http://stock.jrj.com.cn/2020/09/27190230844247.shtml",
    "datetime": "2020-09-27 19:02:52",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]热烈祝贺翰宇药业投资企业——健麾信息成功过会!",
    "href": "http://stock.jrj.com.cn/2020/09/09000031130819.shtml",
    "datetime": "2020-09-09 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]湖北省副省长徐文海一行莅临翰宇药业武汉公司指导疫后重振工作",
    "href": "http://stock.jrj.com.cn/2020/09/09000030710627.shtml",
    "datetime": "2020-09-09 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]南山区政协主席陈军一行莅临我司视察调研",
    "href": "http://stock.jrj.com.cn/2020/09/09000031196353.shtml",
    "datetime": "2020-09-09 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]周先旺与深圳翰宇药业董事长曾少贵座谈",
    "href": "http://stock.jrj.com.cn/2020/09/07000030704284.shtml",
    "datetime": "2020-09-07 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]云南省科学技术院院长侯树谦到翰宇药业大理公司调研并签订合作协议并签订合作协议",
    "href": "http://stock.jrj.com.cn/2020/09/07000030696415.shtml",
    "datetime": "2020-09-07 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业2020年上半年净利4710万下滑38.57% 本期利息收入减少",
    "href": "http://stock.jrj.com.cn/2020/08/17104430516278.shtml",
    "datetime": "2020-08-17 10:44:27",
    "code": "300199"
  },
  {
    "title": "连亏两年后今年中报净利再降四成 翰宇药业退市“钟声”会不会敲响",
    "href": "http://stock.jrj.com.cn/2020/08/14073530541688.shtml",
    "datetime": "2020-08-14 07:35:00",
    "code": "300199"
  },
  {
    "title": "连亏两年后今年中报净利再降四成 翰宇药业退市“钟声”会不会敲响",
    "href": "http://stock.jrj.com.cn/2020/08/14073530497713.shtml",
    "datetime": "2020-08-14 07:35:00",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业7月30日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/30180730386351.shtml",
    "datetime": "2020-07-30 18:07:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]区人大常委会主任饶红蕾一行走访翰宇药业",
    "href": "http://stock.jrj.com.cn/2020/07/26000030648072.shtml",
    "datetime": "2020-07-26 00:00:00",
    "code": "300199"
  },
  {
    "title": "【龙虎榜】翰宇药业7月24日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2020/07/24180830334814.shtml",
    "datetime": "2020-07-24 18:08:52",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]武汉市长周先旺一行赴翰宇武汉公司实地考察",
    "href": "http://stock.jrj.com.cn/2020/07/24000030333710.shtml",
    "datetime": "2020-07-24 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]清华大学深圳国际研究生院邢教授、马岚教授一行来访翰宇药业",
    "href": "http://stock.jrj.com.cn/2020/07/16000030259966.shtml",
    "datetime": "2020-07-16 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇积极支援抗疫 投建口罩生产线",
    "href": "http://stock.jrj.com.cn/2020/07/10000030648073.shtml",
    "datetime": "2020-07-10 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]深圳市市委常委杨洪莅临我司调研",
    "href": "http://stock.jrj.com.cn/2020/07/10000030217427.shtml",
    "datetime": "2020-07-10 00:00:00",
    "code": "300199"
  },
  {
    "title": "快讯：翰宇药业急速拉升7.84% 主力资金净流入1505.34万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/07/07135230166410.shtml",
    "datetime": "2020-07-07 13:52:05",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业紧急驰援中部战区总医院医患人员防控药品",
    "href": "http://stock.jrj.com.cn/2020/06/23000030648074.shtml",
    "datetime": "2020-06-23 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业“峥嵘二十载,扬帆创未来”2020年年会暨2019年度荣誉表彰大会成功举办",
    "href": "http://stock.jrj.com.cn/2020/06/23000030102341.shtml",
    "datetime": "2020-06-23 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业总裁余品香一行造访清华大学深圳国际研究生院",
    "href": "http://stock.jrj.com.cn/2020/06/23000030003300.shtml",
    "datetime": "2020-06-23 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：获得德国药品上市许可",
    "href": "http://stock.jrj.com.cn/2020/05/06121629597932.shtml",
    "datetime": "2020-05-06 12:16:08",
    "code": "300199"
  },
  {
    "title": "翰宇药业2020年一季度净利2242.02万下滑56.93% 运营成本有所增加",
    "href": "http://stock.jrj.com.cn/2020/05/04112829528592.shtml",
    "datetime": "2020-05-04 11:28:37",
    "code": "300199"
  },
  {
    "title": "翰宇药业2019年亏损8.85亿较上年同期亏损增大 董事长薪酬202.94万",
    "href": "http://stock.jrj.com.cn/2020/05/03145529497536.shtml",
    "datetime": "2020-05-03 14:55:06",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]情系深圳 共同抗疫——翰宇药业爱心捐赠药品和物资回馈深圳",
    "href": "http://stock.jrj.com.cn/2020/04/16000030648075.shtml",
    "datetime": "2020-04-16 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]南山区政协主席陈军一行莅临我司视察调研",
    "href": "http://stock.jrj.com.cn/2020/04/14000029283014.shtml",
    "datetime": "2020-04-14 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]热烈庆祝翰宇创新产业大楼主体结构喜封金顶",
    "href": "http://stock.jrj.com.cn/2020/04/14000029810702.shtml",
    "datetime": "2020-04-14 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/10134029256227.shtml",
    "datetime": "2020-04-10 13:40:01",
    "code": "300199"
  },
  {
    "title": "翰宇药业聘请杨笛担任公司副总裁",
    "href": "http://stock.jrj.com.cn/2020/04/06212729215855.shtml",
    "datetime": "2020-04-06 21:27:03",
    "code": "300199"
  },
  {
    "title": "翰宇药业全资子公司取得医疗器械注册证及医疗器械产品出口销售证明",
    "href": "http://stock.jrj.com.cn/2020/04/03204129189579.shtml",
    "datetime": "2020-04-03 20:41:44",
    "code": "300199"
  },
  {
    "title": "翰宇药业：全资子公司取得医疗器械注册证及医疗器械产品出口销售证明",
    "href": "http://stock.jrj.com.cn/2020/04/03160129187623.shtml",
    "datetime": "2020-04-03 16:01:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：口罩出口业务已形成订单",
    "href": "http://stock.jrj.com.cn/2020/03/26111129116576.shtml",
    "datetime": "2020-03-26 11:11:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业依替巴肽注射液获FDA注册批件",
    "href": "http://stock.jrj.com.cn/2020/03/23215929086080.shtml",
    "datetime": "2020-03-23 21:59:57",
    "code": "300199"
  },
  {
    "title": "翰宇药业：依替巴肽注射液获美国FDA注册批件",
    "href": "http://stock.jrj.com.cn/2020/03/23212129085831.shtml",
    "datetime": "2020-03-23 21:21:02",
    "code": "300199"
  },
  {
    "title": "翰宇药业：依替巴肽注射液获得美国FDA注册批件",
    "href": "http://stock.jrj.com.cn/2020/03/23202629085569.shtml",
    "datetime": "2020-03-23 20:26:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：子公司口罩产品获欧盟CE认证",
    "href": "http://stock.jrj.com.cn/2020/03/20214229072029.shtml",
    "datetime": "2020-03-20 21:42:07",
    "code": "300199"
  },
  {
    "title": "翰宇药业：口罩产品获欧盟CE认证 接到北美、欧盟等地客户询单",
    "href": "http://stock.jrj.com.cn/2020/03/20211729071929.shtml",
    "datetime": "2020-03-20 21:17:00",
    "code": "300199"
  },
  {
    "title": "[互动]翰宇药业：武汉基地正在积极开展复工复产前的准备工作",
    "href": "http://stock.jrj.com.cn/2020/03/16140729031799.shtml",
    "datetime": "2020-03-16 14:07:21",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]抗击疫情 翰宇在行动",
    "href": "http://stock.jrj.com.cn/2020/03/11000030648065.shtml",
    "datetime": "2020-03-11 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业拟建设11条医用口罩生产线 年产量约4亿只",
    "href": "http://stock.jrj.com.cn/2020/03/10230128994325.shtml",
    "datetime": "2020-03-10 23:01:22",
    "code": "300199"
  },
  {
    "title": "翰宇药业：拟建设11条医用口罩生产线 年产量约4亿只",
    "href": "http://stock.jrj.com.cn/2020/03/10210928993889.shtml",
    "datetime": "2020-03-10 21:09:55",
    "code": "300199"
  },
  {
    "title": "翰宇药业：子公司拟新增建设6条医用口罩生产线",
    "href": "http://stock.jrj.com.cn/2020/03/10210228993865.shtml",
    "datetime": "2020-03-10 21:02:14",
    "code": "300199"
  },
  {
    "title": "翰宇药业：拟定增募资不超9.5亿元用于补充流动资金及偿还贷款",
    "href": "http://stock.jrj.com.cn/2020/03/05222828961729.shtml",
    "datetime": "2020-03-05 22:28:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：拟定增募资不超9.52亿元",
    "href": "http://stock.jrj.com.cn/2020/03/05194928961000.shtml",
    "datetime": "2020-03-05 19:49:07",
    "code": "300199"
  },
  {
    "title": "翰宇药业：拟定增募资不超9.52亿元 用于补充流动资金和偿还银行贷款",
    "href": "http://stock.jrj.com.cn/2020/03/05193728960929.shtml",
    "datetime": "2020-03-05 19:37:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业副总裁陶安进辞职 2018年薪酬为95万元",
    "href": "http://stock.jrj.com.cn/2020/02/29155528919938.shtml",
    "datetime": "2020-02-29 15:55:28",
    "code": "300199"
  },
  {
    "title": "翰宇药业2019年亏损8.72亿元 亏损程度有所增加 销售收入同比下降",
    "href": "http://stock.jrj.com.cn/2020/02/28173628915660.shtml",
    "datetime": "2020-02-28 17:36:29",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]区人大常委会主任饶红蕾走访翰宇药业",
    "href": "http://stock.jrj.com.cn/2020/02/28000028916652.shtml",
    "datetime": "2020-02-28 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]深圳市人大常委会副主任蒋宇扬一行调研翰宇药业",
    "href": "http://stock.jrj.com.cn/2020/02/28000028933489.shtml",
    "datetime": "2020-02-28 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业向银行申请不超过16亿元综合授信额度及为子公司1.5亿元授信提供担保",
    "href": "http://stock.jrj.com.cn/2020/02/20211928864512.shtml",
    "datetime": "2020-02-20 21:19:18",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]深圳市副市长王立新一行莅临翰宇药业调研",
    "href": "http://stock.jrj.com.cn/2020/02/19000028933488.shtml",
    "datetime": "2020-02-19 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：醋酸阿托西班注射液获西班牙上市许可 有利于提升公司国际品牌影响力",
    "href": "http://stock.jrj.com.cn/2020/02/16184128835046.shtml",
    "datetime": "2020-02-16 18:41:10",
    "code": "300199"
  },
  {
    "title": "翰宇药业的醋酸阿托西班注射液获得西班牙上市许可",
    "href": "http://stock.jrj.com.cn/2020/02/16181528835013.shtml",
    "datetime": "2020-02-16 18:15:15",
    "code": "300199"
  },
  {
    "title": "翰宇药业：醋酸阿托西班注射液获西班牙上市许可",
    "href": "http://stock.jrj.com.cn/2020/02/16174128834867.shtml",
    "datetime": "2020-02-16 17:41:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]上海银行董事长金煜一行走访翰宇药业",
    "href": "http://stock.jrj.com.cn/2020/02/12000028933487.shtml",
    "datetime": "2020-02-12 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业积极支援抗疫 投建口罩生产线",
    "href": "http://stock.jrj.com.cn/2020/02/11181228810380.shtml",
    "datetime": "2020-02-11 18:12:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业签署合作协议 涉足工业大麻产业",
    "href": "http://stock.jrj.com.cn/2020/02/11000028933486.shtml",
    "datetime": "2020-02-11 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇积极支援抗疫 投建口罩生产线",
    "href": "http://stock.jrj.com.cn/2020/02/11000028808145.shtml",
    "datetime": "2020-02-11 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：投资建设5条自动化医用口罩生产线 年产量约2亿只",
    "href": "http://stock.jrj.com.cn/2020/02/10210828804825.shtml",
    "datetime": "2020-02-10 21:08:56",
    "code": "300199"
  },
  {
    "title": "翰宇药业：子公司拟投资建设医用口罩生产线",
    "href": "http://stock.jrj.com.cn/2020/02/10201328804677.shtml",
    "datetime": "2020-02-10 20:13:46",
    "code": "300199"
  },
  {
    "title": "翰宇药业子公司投资建设医用口罩生产线",
    "href": "http://stock.jrj.com.cn/2020/02/10200428804642.shtml",
    "datetime": "2020-02-10 20:04:55",
    "code": "300199"
  },
  {
    "title": "翰宇药业：子公司投资建设医用口罩生产线",
    "href": "http://stock.jrj.com.cn/2020/02/10193428804513.shtml",
    "datetime": "2020-02-10 19:34:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：捐赠药品防护服支援抗击新型冠状病毒感染的肺炎疫情",
    "href": "http://stock.jrj.com.cn/2020/02/09220328798823.shtml",
    "datetime": "2020-02-09 22:03:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业捐赠13余万支疫苗 助力一线人员抗击疫情",
    "href": "http://stock.jrj.com.cn/2020/02/09173428798388.shtml",
    "datetime": "2020-02-09 17:34:29",
    "code": "300199"
  },
  {
    "title": "驰援抗疫一线 翰宇药业累计捐赠药品物资超1200万元",
    "href": "http://stock.jrj.com.cn/2020/02/07212728795147.shtml",
    "datetime": "2020-02-07 21:27:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业累计捐赠1200万元物资",
    "href": "http://stock.jrj.com.cn/2020/02/07193828794788.shtml",
    "datetime": "2020-02-07 19:38:03",
    "code": "300199"
  },
  {
    "title": "翰宇药业捐赠一批胸腺法新产品给深圳市三院",
    "href": "http://stock.jrj.com.cn/2020/02/07184728794468.shtml",
    "datetime": "2020-02-07 18:47:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业荣获“南山区2018年度经济增长贡献百强企业”称号",
    "href": "http://stock.jrj.com.cn/2020/02/07000028933485.shtml",
    "datetime": "2020-02-07 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：多款产品被多地列入防控药品清单",
    "href": "http://stock.jrj.com.cn/2020/02/04202828768553.shtml",
    "datetime": "2020-02-04 20:28:09",
    "code": "300199"
  },
  {
    "title": "翰宇药业：多款产品被列入防控药品清单",
    "href": "http://stock.jrj.com.cn/2020/02/04201128768520.shtml",
    "datetime": "2020-02-04 20:11:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业紧急驰援中部战区总医院医患人员防控药品",
    "href": "http://stock.jrj.com.cn/2020/02/03000028756064.shtml",
    "datetime": "2020-02-03 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]情系深圳 共同抗疫——翰宇药业爱心捐赠药品和物资回馈深圳",
    "href": "http://stock.jrj.com.cn/2020/02/02000028750663.shtml",
    "datetime": "2020-02-02 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：提前复工保障肺炎防控药品生产供应",
    "href": "http://stock.jrj.com.cn/2020/01/29120028740818.shtml",
    "datetime": "2020-01-29 12:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：第一时间将狙击疫情的药品“胸腺五肽”、“胸腺法新”供给到一线",
    "href": "http://stock.jrj.com.cn/2020/01/28050428738587.shtml",
    "datetime": "2020-01-28 05:04:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]抗击疫情 翰宇在行动",
    "href": "http://stock.jrj.com.cn/2020/01/27000028750664.shtml",
    "datetime": "2020-01-27 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业2019年加大亏损额 预计亏损8.75亿元-8.8亿元",
    "href": "http://stock.jrj.com.cn/2020/01/23121228727045.shtml",
    "datetime": "2020-01-23 12:12:52",
    "code": "300199"
  },
  {
    "title": "翰宇药业：2019年预亏8.75亿-8.8亿元",
    "href": "http://stock.jrj.com.cn/2020/01/22211828722834.shtml",
    "datetime": "2020-01-22 21:18:20",
    "code": "300199"
  },
  {
    "title": "翰宇药业：2019年预亏8.75亿元-8.8亿元",
    "href": "http://stock.jrj.com.cn/2020/01/22192028722377.shtml",
    "datetime": "2020-01-22 19:20:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：盐酸曲美他嗪缓释片拟中选第二批国家药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/20141128705588.shtml",
    "datetime": "2020-01-20 14:11:00",
    "code": "300199"
  },
  {
    "title": "午间公告：多家公司披露2019年业绩预告；翰宇药业药品拟中选全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2020/01/20120028705193.shtml",
    "datetime": "2020-01-20 12:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：醋酸阿托西班注射液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/09205428651777.shtml",
    "datetime": "2020-01-09 20:54:19",
    "code": "300199"
  },
  {
    "title": "翰宇药业：醋酸阿托西班注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/09194028651562.shtml",
    "datetime": "2020-01-09 19:40:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业现金流趋紧4亿回购终止 净利降127%八名高管离职",
    "href": "http://stock.jrj.com.cn/2020/01/02075028615289.shtml",
    "datetime": "2020-01-02 07:50:55",
    "code": "300199"
  },
  {
    "title": "翰宇药业终止回购公司股份",
    "href": "http://stock.jrj.com.cn/2019/12/31210628612425.shtml",
    "datetime": "2019-12-31 21:06:33",
    "code": "300199"
  },
  {
    "title": "翰宇药业：终止回购公司股份",
    "href": "http://stock.jrj.com.cn/2019/12/31204328612364.shtml",
    "datetime": "2019-12-31 20:43:55",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]第二批药品带量采购结果出炉 翰宇药业盐酸曲美他嗪中标",
    "href": "http://stock.jrj.com.cn/2019/12/30000028712340.shtml",
    "datetime": "2019-12-30 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业“峥嵘二十载,扬帆创未来”2020年年会暨2019年度荣誉表彰大会成功举办",
    "href": "http://stock.jrj.com.cn/2019/12/30000028608052.shtml",
    "datetime": "2019-12-30 00:00:00",
    "code": "300199"
  },
  {
    "title": "10年老员工伍柯瑾出任翰宇药业证券代表 先后在研发中心总裁办工作",
    "href": "http://stock.jrj.com.cn/2019/12/20090928560807.shtml",
    "datetime": "2019-12-20 09:09:09",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]热烈庆祝翰宇创新产业大楼主体结构喜封金顶",
    "href": "http://stock.jrj.com.cn/2019/11/13000028393507.shtml",
    "datetime": "2019-11-13 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]热烈庆祝翰宇创新产业大楼主体结构喜封金顶",
    "href": "http://stock.jrj.com.cn/2019/11/11000028381537.shtml",
    "datetime": "2019-11-11 00:00:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业：利拉鲁肽注射液药品注册申请获药监局受理",
    "href": "http://stock.jrj.com.cn/2019/10/31201028334973.shtml",
    "datetime": "2019-10-31 20:10:15",
    "code": "300199"
  },
  {
    "title": "翰宇药业：利拉鲁肽注射液注册申请已获正式受理",
    "href": "http://stock.jrj.com.cn/2019/10/31200028334948.shtml",
    "datetime": "2019-10-31 20:00:05",
    "code": "300199"
  },
  {
    "title": "翰宇药业：利拉鲁肽注射液药品注册申请获受理",
    "href": "http://stock.jrj.com.cn/2019/10/31195428334920.shtml",
    "datetime": "2019-10-31 19:54:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业前三季度业绩预亏 股价今日跌停",
    "href": "http://stock.jrj.com.cn/2019/10/15201128251929.shtml",
    "datetime": "2019-10-15 20:11:56",
    "code": "300199"
  },
  {
    "title": "翰宇药业2019年前三季度净利亏损7700万-8200万 销售推广困难增加",
    "href": "http://stock.jrj.com.cn/2019/10/15133628249486.shtml",
    "datetime": "2019-10-15 13:36:45",
    "code": "300199"
  },
  {
    "title": "前三季净利同比预亏超1倍 翰宇药业跌停创逾六年新低",
    "href": "http://stock.jrj.com.cn/2019/10/15102428248454.shtml",
    "datetime": "2019-10-15 10:24:54",
    "code": "300199"
  },
  {
    "title": "[安科生物]深圳翰宇药业股份有限公司执行总裁余品香女士赴安科参观交流",
    "href": "http://stock.jrj.com.cn/2019/08/16000030999773.shtml",
    "datetime": "2019-08-16 00:00:00",
    "code": "300199"
  },
  {
    "title": "[安科生物]深圳翰宇药业股份有限公司执行总裁余品香女士赴安科参观交流",
    "href": "http://stock.jrj.com.cn/2019/08/16000027989684.shtml",
    "datetime": "2019-08-16 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]深圳市副市长王立新一行莅临翰宇药业调研",
    "href": "http://stock.jrj.com.cn/2019/08/09000028067885.shtml",
    "datetime": "2019-08-09 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]深圳市人大常委会副主任蒋宇扬一行调研翰宇药业",
    "href": "http://stock.jrj.com.cn/2019/08/09000027953537.shtml",
    "datetime": "2019-08-09 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]深圳市副市长王立新一行莅临翰宇药业调研",
    "href": "http://stock.jrj.com.cn/2019/07/19000027863399.shtml",
    "datetime": "2019-07-19 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]上海银行董事长金煜一行走访翰宇药业",
    "href": "http://stock.jrj.com.cn/2019/07/19000028067881.shtml",
    "datetime": "2019-07-19 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]深圳市经信委主任贾兴东一行莅临翰宇药业调研",
    "href": "http://stock.jrj.com.cn/2019/07/19000027912808.shtml",
    "datetime": "2019-07-19 00:00:00",
    "code": "300199"
  },
  {
    "title": "受医改政策影响：翰宇药业净利润下滑45%至65%",
    "href": "http://stock.jrj.com.cn/2019/07/12200727833791.shtml",
    "datetime": "2019-07-12 20:07:32",
    "code": "300199"
  },
  {
    "title": "翰宇药业：盐酸曲美他嗪缓释片获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/07/04162227797241.shtml",
    "datetime": "2019-07-04 16:22:27",
    "code": "300199"
  },
  {
    "title": "翰宇药业：醋酸特利加压素获印尼药品上市许可批准",
    "href": "http://stock.jrj.com.cn/2019/06/18183227720977.shtml",
    "datetime": "2019-06-18 18:32:35",
    "code": "300199"
  },
  {
    "title": "翰宇药业：获得印度尼西亚药品上市许可批准",
    "href": "http://stock.jrj.com.cn/2019/06/18182127720928.shtml",
    "datetime": "2019-06-18 18:21:00",
    "code": "300199"
  },
  {
    "title": "翰宇药业净利亏3.4亿 计提商誉减值和坏账准备被问询",
    "href": "http://stock.jrj.com.cn/2019/05/15073927571394.shtml",
    "datetime": "2019-05-15 07:39:03",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]“聚势合力,共赢未来”翰宇药业商务交流会",
    "href": "http://stock.jrj.com.cn/2019/05/14000027912809.shtml",
    "datetime": "2019-05-14 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业签署合作协议 涉足工业大麻产业",
    "href": "http://stock.jrj.com.cn/2019/05/14000028067880.shtml",
    "datetime": "2019-05-14 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]翰宇药业“热爱深圳、保护环境”主题徒步活动圆满成功",
    "href": "http://stock.jrj.com.cn/2019/05/14000027776409.shtml",
    "datetime": "2019-05-14 00:00:00",
    "code": "300199"
  },
  {
    "title": "[翰宇药业]上海银行董事长金煜一行走访翰宇药业",
    "href": "http://stock.jrj.com.cn/2019/05/14000027570995.shtml",
    "datetime": "2019-05-14 00:00:00",
    "code": "300199"
  }
]